TY  - BOOK
AU  - Rania Salah Abdelaziz
AU  - Basma Mostafa Elgamal , 
AU  - Magda Mahmoud A. Assem , 
AU  - Sherine Ibrahim Salem , 
TI  - The role of CD86 and vascular endothelial growth factor in acute myeloid leukemia / 
PY  - 2009///
CY  - Cairo : 
PB  - Rania Salah Abdelaziz , 
KW  - CD80
KW  - CD86
KW  - Vasclar Endothelial Growth Factor
N1  - Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology; Issued also as CD
N2  - AML is the most frequent type of leukemia in adult . Recognition and destruction of leukemic blasts by the immune system is of great interest for the development of immuntherapeutic strategies in AML . T- cell activation requires T-cell receptor recognition and binding to major histocompatability complex (MHC) complex/angtigen presented by an antigen-presenting cell (APC) and the binding of ligands for the T - cell costimulatory receptors CD28 and CTLA - 4, ie, CD80/B7 - 1 and CD86/B7 - 2, respectively
UR  - http://172.23.153.220/th.pdf
ER  -